It was shown that PTEN promoter hypermethylation suppresses PTEN expression and activates AKT in tamoxifen-resisted breast cancer cells, and treatment with 5-aza reduces PTEN methylation and sensitizes cells to tamoxifen-induced cytotoxicity31. This evidence concerns the gene PTEN and breast carcinoma.